Stock Markets July 31, 2026 08:43 AM

Six Stocks That Fit a True 'Set-and-Forget' Playbook for Long-Term Holders

A screening for persistent compounding uncovers leaders across AI, pharma, networking, security and digital infrastructure

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
NVDA AVGO META LLY ANET

A rules-based screener targeting sustained top-line growth, strong returns on capital, healthy balance sheets and meaningful five-year price appreciation returned 68 U.S. names. Six companies emerge as archetypal long-term compounders: NVIDIA, Broadcom, Meta Platforms, Eli Lilly, Arista Networks and Fortinet. Each combines durable economics with scale, though valuation and demand-cycle risks vary.

Six Stocks That Fit a True 'Set-and-Forget' Playbook for Long-Term Holders
NVDA AVGO META LLY ANET
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • A quantitative screen emphasizing 5-year revenue CAGRs above 8%, ROE above 15%, financial health scores above 2.5, and 5-year price returns above 50% produced 68 U.S. matches; six names stood out as durable compounders.
  • The selected companies span AI compute and custom silicon (NVIDIA, Broadcom), digital advertising (Meta Platforms), pharmaceuticals with high-margin blockbusters (Eli Lilly), data-center networking (Arista Networks), and cybersecurity platform solutions (Fortinet).
  • Valuation nuances differ across the list: some names show meaningful fair-value upside while others trade at premium multiples reflecting their durable economics and growth prospects.

Investors seeking a genuine "set-and-forget" holding require one hard constraint: a business capable of compounding through multiple cycles without active management from shareholders. Using that idea as a filter, a quantitative screen limited to U.S.-listed equities and calibrated for sustained growth and balance-sheet resilience identified 68 matches. From that universe, six firms rise to the top as businesses that can plausibly be owned for the long haul without constant monitoring. They represent several market vectors: AI compute and custom silicon, high-margin advertising platforms, pharmaceutical blockbuster pipelines, data-center networking and enterprise cybersecurity.


The Compounding Criteria

The selection and ranking emphasized four pillars: five-year revenue compound annual growth rate (CAGR), financial health, return on invested capital (ROIC) and forward valuation. The screen required 5-year revenue CAGRs above 8%, returns on equity above 15%, financial health scores above 2.5, and five-year price returns above 50%. Names concentrated where durable business economics and growth were driving returns rather than mere multiple expansion. Cyclical businesses, the company PLTR (excluded per the requester) and any name whose gains were primarily attributable to re-rating rather than operational expansion were set aside.

Below is a compact summary of the six names and the key metrics used to evaluate them:

Company 5Y Rev CAGR ROIC Gross Margin Fwd P/E Fair Value Upside Health 5Y Return
NVIDIA (NVDA) 66.9% 95.5% 74.1% 21.6x +32.3% Excellent +975.8%
Broadcom (AVGO) 21.7% 20.0% 76.3% 32.2x +11.1% Great +769.9%
Meta Platforms (META) 18.5% 22.8% 81.7% 17.1x +6.2% Great +61.2%
Eli Lilly (LLY) 21.6% 45.0% 82.8% 33.7x +4.7% Great +415.5%
Arista Networks (ANET) 31.2% 30.3% 63.5% 46.6x -8.3% Great +637.7%
Fortinet (FTNT) 21.3% N/A N/A 54.1x -12.0% Great +179.7%

NVIDIA - The Compounding Machine

NVIDIA stands out for its extraordinary capital efficiency. With a 95.5% ROIC and $119.08 billion in last-twelve-month free cash flow, it ranks among the most cash-generative large-cap businesses shown in the screen. The stock traded in pre-market at $196.69, reflecting a forward price-to-earnings ratio of 21.6x. Based on the calculated fair value, the implied upside is +32.3% from those pre-market levels. The principal valuation caveat is that the AI infrastructure cycle carries optimistic expectations; any meaningful slowdown in demand would weigh on results. For investors with a multi-year, five- to ten-year horizon or longer, the profile described here treats the AI compute buildout as a multi-decade secular trend.

Key metrics: Market cap $4.72 trillion, FCF (LTM) $119.08B, Fwd P/E 21.6x, FV Upside +32.3%.


Broadcom - The Quiet Colossus

Broadcom offers a combination of high gross margins and recurring revenue tied to entrenched technology stacks. The company's gross margin is 76.3% and last-twelve-month free cash flow is $32.76 billion. Its product mix spans custom AI silicon, VMware cloud infrastructure and networking, creating switching costs that are architectural rather than tactical. Broadcom's forward P/E is 32.2x with an implied fair-value upside of +11.1%, suggesting the stock is not inexpensive but also not markedly stretched relative to fundamentals.

Key metrics: Market cap $1.85 trillion, Gross margin 76.3%, FCF (LTM) $32.76B, Fwd P/E 32.2x, FV Upside +11.1%.


Meta Platforms - The Cheapest Compounder on the List

Meta combines high margins with considerable free cash flow. Its 81.7% gross margin accompanies $40.98 billion in last-twelve-month free cash flow and a forward P/E of 17.1x, making it the cheapest mega-cap compounder among the six by that measure. Revenue growth has been mid-to-high teens on a five-year basis and the company's social platforms maintain large daily active user footprints that exhibit low churn. The article notes regulatory risks and the heavy investment in Reality Labs as the principal uncertainties that counterbalance the valuation case.

Key metrics: Market cap $1.37 trillion, Gross margin 81.7%, FCF (LTM) $40.98B, Fwd P/E 17.1x, FV Upside +6.2%.


Eli Lilly - Pharma's Decade

Eli Lilly's argument within the screen rests on a high-return pharmaceutical franchise and a valuable pipeline. The company posts a 45.0% ROIC and 82.8% gross margin driven by patent-protected blockbusters. The global market opportunity for the GLP-1 class cited in the screening context is large, and Lilly's products such as Mounjaro and Zepbound are highlighted as central to that runway. The forward P/E is 33.7x and last-twelve-month free cash flow is $11.82 billion. The principal drug-centric risk flagged is the eventuality of patent expirations and biosimilar competition after 2030.

Key metrics: Pre-market price $1,151.56, Market cap $1.03 trillion, ROIC 45.0%, FCF (LTM) $11.82B, Fwd P/E 33.7x.


Arista Networks - AI's Plumbing Provider

Arista supplies networking equipment that underpins AI data-center deployments. It reported a five-year revenue CAGR of 31.2% and a 30.3% ROIC, reflecting strong pricing power in cloud and enterprise networking. The stock traded in pre-market at $174.80, after recent momentum from an earlier intraday gain. Valuation is the primary tension: Arista's forward P/E at 46.6x implies investors are paying a premium for exposure to the infrastructure layer of the AI buildout rather than the volatility inherent to chipmakers.

Key metrics: Pre-market price $174.80, Market cap $215.35B, Rev CAGR 5Y 31.2%, ROIC 30.3%, 5Y Return +637.7%.


Fortinet - The Cybersecurity Fortress

Fortinet's security platform aims to lock customers into a multi-product architecture, producing high renewal rates and recurring revenue. The company shows a 21.3% revenue CAGR over five years and a return on equity of 132.4%. Financial health is characterized as "Great." Cybersecurity spending exhibits defensive characteristics, driven in part by regulatory and insurance-related imperatives, which supports the idea that security budgets are persistent through economic cycles. Fortinet trades at a high forward multiple, 54.1x, reflecting those durable economics and investor willingness to pay for recurring revenue streams.

Key metrics: Market cap $113.01B, Rev CAGR 5Y 21.3%, ROE 132.4%, 5Y Return +179.7%, Fwd P/E 54.1x.


One-line theses

  • NVDA - Own the picks-and-shovels of the AI gold rush.
  • AVGO - The toll booth on cloud and AI custom silicon.
  • META - The world's cheapest high-margin digital ad empire.
  • LLY - A decade of GLP-1 runway that is only beginning to play out.
  • ANET - AI data-center networking exposure with relative stability.
  • FTNT - Cybersecurity is a regulated and contract-driven priority.

Each name meets the screen's quality thresholds, but investors must weigh valuation and demand-cycle risk against the durable economics highlighted above when considering a long-term, "set-and-forget" allocation.

Risks

  • Demand deceleration in AI infrastructure could materially affect companies exposed to AI compute spending - this primarily impacts NVIDIA and Arista Networks.
  • Patent expirations and biosimilar competition after 2030 pose a long-term risk to pharmaceutical franchises dependent on patent-protected blockbusters - this impacts Eli Lilly.
  • High forward valuations on some names mean that earnings or growth disappointments could lead to sharp share-price declines - this is relevant for Arista Networks and Fortinet given their elevated forward P/E ratios.

More from Stock Markets

Treasury Anti-Money Laundering Director Andrea Gacki to Join Citigroup as Global Head of Sanctions Jul 31, 2026 Evercore ISI Keeps Apple as Top Pick in IT Hardware & Networking After June Quarter Jul 31, 2026 AI-Focused Hedge Fund Suffered 67% Drop in July After Concentrated AI Losses Jul 31, 2026 Fitch Lowers Senior Secured Rating on Aston Martin Capital Amid New Loan Structure Jul 31, 2026 Warsaw market closes higher as WIG30 hits fresh record; energy and media stocks lead gains Jul 31, 2026